Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with Euthyroid Graves' disease

Thyroid

Volumn 8, Issue 10, 1998, Pages 881-885

  Kashiwai, Taku ^a   Tada, Hisato ^a   Watanabe, Yukihiko ^a   Shimaoka, Yuki ^a   Yagoro, Aya ^a   Hidaka, Yoh ^a   Fujikado, Takashi ^a   Amino, Nobuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; LIOTHYRONINE; MICROSOME ANTIBODY; PROTIRELIN; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HORMONE RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROTIRELIN TEST; THYROID GLAND;

EID: 0031733733     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.881     Document Type: Article

References (31)

1. Lawton NF, Ekins RP, Nabarro JDN 1971 Failure of pituitary response to thyrotrotrophin-releasing hormone in euthyroid Graves' disease. Lancet 2:14-16.
2. Franco PS, Hershman JM, Haigler D, Pittman JA 1973 Response to thyrotropin-releasing hormone compared with thyroid suppression tests in euthyroid Graves' disease. Metabolism 22:1357-1365.
3. Shimizu T, Shishiba Y 1973 Normal serum triiodothyronine concentration and the lack of TSH response to TRH in patients with euthyroid Graves' disease. Endocrinol Jpn 20:527-528.
4. Solmon DH, Chopra IJ, Chopra U, Smith FJ 1977 Identification of subgroups of euthyroid Graves' opthalmopathy. N Engl J Med 296:181-186.
5. Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J 1988 Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease. Clin Endocrinol 29:357-366.
6. Bahn RS, Heufelder AE 1993 Pathogenesis of Graves' ophthalmopathy. N Engl J Med 329:1468-1475.
7. Weetman AP 1992 Update: Thyroid-associated ophthalmopathy. Autoimmunity 12:215-222.
8. Kashiwai T, Tada H, Asahi K, Hidaka Y, Tamaki H, Iwatani Y, Amino N 1995 Significance of thyroid stimulating antibody and long term follow up in patients with euthyroid Graves' disease. Endocr J 42:405-412.
9. Feliciello A, Porcellini A, Ciullo I, Bonavolonta G, Avvedimento EV, Fenzi G 1993 Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342:337-338.
10. Heufelder AE 1995 Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy. Thyroid 5:331-339.
11. Major BJ, Cures A, Frauman AG 1997 The full length and splice variant thyrotropin receptor is expressed exclusively in skeletal muscle of extraocular origin: A link to the pathogenesis of Graves' ophthalmopathy. Biochem Biophys Res Commun 230:493-496.
12. Watanabe Y, Tahara K, Hirai A, Tada H, Kohn LD, Amino N 1997 Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor. Thyroid 7:13-19.
13. Hidaka Y, Tamaki H, Iwatani Y, Tada H, Mitsuda N, Amino N 1994 Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy. Clin Endocrinol 41:15-20.
14. Hall R, Doniach D, Kirkham K, Kabir DE 1970 Ophthalmic Graves' disease. Lancet 1:375-378.
15. Teng CS, Smith BR, Clayton B, Evered DC, Clark F, Hall R 1977 Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease. Clin Endocrinol 6:207-211.
16. Perrild H, Feldt-Rasmussen U, Bech K, Ahlgren P, Hansen JM 1984 The differential diagnostic problems in unilateral euthyroid Graves' opthalmopathy. Acta Endocrinol 106:471-476.
17. Peter SA 1986 Euthyroid Graves' disease. Am J Med 80:1197-1198.
18. Kosugi S, Inoue D, Sugawa H, Enomoto T, Mori T, Imura H 1990 Similarity and dissimilarity between clinical and laboratory findings, especially anti-thyrotropin receptor antibody in opthalmic Graves' disease without persistent hyperthyroidism and hyperthyroid Graves' disease. Endoclinol Jpn 37:343-354.
19. Wyse EP, McConahey WM, Woolner LB, Scholz DA, Kearns TP 1968 Ophthalmopathy without hyperthyroidism in patients with histologic Hashimoto's thyroiditis. J Clin Endocrinol 28:1623-1629.
20. Kalman K, Leovey A, Kelenhegyi C, Kolozsvari L, Bako GY 1989 Euthyroid infiltrative ophthalmopathy: Clinical-immunological characteristics. Acta Medica Hungarica 46:101-108.
21. Tamai H, Nagai K, Uehata S, Komaki G, Kiyohara K, Miyauchi A, Kuma K, Kumagai LF, Nagataki S 1990 Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease. Exp Clin Endocrinol 96:279-287.
22. Werner SC 1955 Euthyroid patients with early eye signs of Graves' disease. Am J Med 16:608-612.
23. Clifton-Bligh P, Silverstein GE, Burke G 1973 Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and euthyroid Graves' disease. J Clin Endocrinol Metab 38:531-538.
24. Jaffiol C, Baldet L, Missonne CL, Papachristou C 1981 T3 kinetics in euthyroid Graves' disease patients who exhibit hyper-responsiveness to TRH after radioiodine treatment. Clin Endocrinol 15:417-421.
25. Notsu K, Oka N, Masaki Y, Furuya H, Kato Y 1991 Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs. J Clin Endocrinol Metab 73:396-400.
26. 4-serumspiegeln bei sogenannter euthyreoter endokriner ophthalmopathie. Endokrinologie 66:67-73.
27. Lawton NF 1979 Exclusion of dysthyroid eye disease as a cause of unilateral proptosis. Trans Ophthal Soc UK 99:226-228.
28. Carlson HE, Hershman JM 1975 The hypothalamic-pituitary-thyroid axis. Med Clin North Am 59:1045-1053.
29. Spencer CA, Schwarzbein D, Guttler RB, Lopresti JS, Nicoloff JT 1993 Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab 76:494-498.
30. Chopra IJ, Chopra U, Orgiazzi J 1973 Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 37:955-967.
31. Tamaki H, Amino N, Iwatani Y, Miyai K 1989 Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease. J Endocrinol Invest 12:47-54.